MDM S.p.A.: Clinical Trials

3 trials sponsored by MDM S.p.A., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 1 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 21Completed 1
Phase 31Completed 1

Follow MDM S.p.A.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Non-Comparative Study to Assess the Efficacy and Safety of the New Food Supplement FaseMETS
Daily administration: 2 tablets FaseMETS a day - Metabolic Syndrome
Not applicableCompletedMDM S.p.A.342017-05-092019-10-01
Choline Alphoscerate-Nimodipine in Vascular Cognitive Impairment
Choline alphoscerate, Placebo - Vascular Cognitive Impairment
Phase 2CompletedAzienda Ospedaliero-Universitaria Careggi622017-05-022020-01-13
Study to Assess the Efficacy and Safety of Tizaspray® Versus Sirdalud®, in Patients With Acute Low Back Pain
Tizaspray® administered intranasally, Sirdalud® 2 mg tablets administered - Low Back Pain
Phase 3CompletedMDM S.p.A.1172016-10-012018-01-16

Conditions studied

Low Back Pain (1)  ·  Metabolic Syndrome (1)

Interventions

Glycerylphosphorylcholine (1)  ·  tizanidine (1)

Countries

Romania (2)  ·  Italy (1)

Top investigators

Antonio Maggi, MD (1)  ·  Doina Rosu, MD (1)

Results publications

PMID 31148099, PMID 33855653

NIH funding

2015 (1)